MYC and glycogen storage disease VI: Overall, these novel MS09:Chol liposomes are endowed with physicochemical properties that may render them more suitable forin vivo siRNA delivery than their MS09:DOPE counterparts, and that their anti-c-myc-siRNA lipoplexes should be developed further as a posttranscriptional intervention treatment modality for mono- and polygenic human diseases.